Syschem (India) Limited (SYSCHEM.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹35.86 (+7.95%) as of
Key statistics
- Market cap
- 1.92B
- P/E (TTM)
- 33.20
- EPS (TTM)
- 1.08
- Dividend yield
- 0.00%
- 52-week range
- 28.81 – 60.95
- Beta
- -0.31
- Revenue (TTM)
- 6.54B
- Profit margin
- 1.16%
- Volume
- 22.21k
About Syschem (India) Limited
Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, and bulk drugs in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialist solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing services. Syschem (India) Limited was incorporated in 1993 and is based in Chandigarh, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Chandigarh, India
- Employees
- 135
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.